Status:
ACTIVE_NOT_RECRUITING
Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS)
Lead Sponsor:
Medtronic
Conditions:
Ventricular Tachycardia
Eligibility:
All Genders
Brief Summary
Medtronic is sponsoring the Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS) to further confirm safety and effectiveness of ventricular iATP therapy in routine clinical practice, follow...
Detailed Description
The iATP PAS is a global, prospective, observational, multi-site registry study. Patients enrolled in the iATP PAS will be prospectively followed in the registry until registry closure, patient death,...
Eligibility Criteria
Inclusion
- Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements
- Patient is intended to receive or is implanted with an iATP-capable device with iATP on in any zone with ventricular ATP therapies programmed.
- Patient is enrolled in the CareLink network for remote device monitoring
Exclusion
- Patient who is, or is expected to be inaccessible for follow-up
- Patient with exclusion criteria required by local law
- Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results
Key Trial Info
Start Date :
August 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 31 2028
Estimated Enrollment :
2200 Patients enrolled
Trial Details
Trial ID
NCT04496518
Start Date
August 1 2020
End Date
January 31 2028
Last Update
October 20 2025
Active Locations (92)
Enter a location and click search to find clinical trials sorted by distance.
1
Southwest EP
Chandler, Arizona, United States, 85226
2
Saint Vincent Heart Clinic Arkansas
Little Rock, Arkansas, United States, 72205-6202
3
Chula Vista Cardiac Center
Chula Vista, California, United States, 91910
4
Cardiovascular Consultants Medical Group (Van Nuys CA)
Van Nuys, California, United States, 91405